Ten-year data from the UK IMPORT LOW trial demonstrate non-inferiority of partial-breast and reduced-dose radiotherapy compared to whole-breast radiotherapy for women with low-risk early breast cancer.
The rates of ipsilateral breast tumour recurrence (IBTR) at 10 years are low and comparable across all treatment arms.
Long-term adverse effects, including breast shrinkage, are similar or lower for partial-breast and reduced-dose groups compared to whole-breast irradiation.
Partial-breast radiotherapy with intensity-modulated techniques is reaffirmed as a standard of care for selected patients.
Study Background and Disease Burden
MedXY registered readers
Sign in free to continue reading
Create or use your MedXY account to unlock the complete article.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.